全身MRI与PET/CT在淋巴瘤骨髓浸润诊断及预后中的作用

岳进; 苏丽萍; 岳进; 苏丽萍

doi:10.3760/cma.j.issn.1673-4114.2016.01.010

[1]

Kwee TC, Kwee RM, Verdonck LF, et al.Magnetic resonance imaging for the detection of bone marrow involvement in malignant lymphoma[J].Br JHaematol, 2008, 141(1):60-68.DOI:10.1111/j.1365-2141.2008.07020.x.

[2]

Adams HJ, Kwee TC, Vermoolen MA, et al.Whole-body MRI for the detection of bone marrow involvement in lymphoma:prospective study in 116 patients and comparison with FDG-PET[J].Eur Radiol, 2013, 23(8):2271-2278.DOI:10.1007/s00330-013-2835-9.

[3]

Daldrup-Link HE, Henning T, Link TM.MR imaging of therapy-induced changes of bone marrow[J].Eur radiol, 2007, 17(3):743-761.DOI:10.1007/s00330-006-0404-1.

[4]

Nakanishi K, Kobayashi M, Nakaguchi K, et al.Whole-body MRI for detecting metastatic bone tumor:diagnostic value of diffusion-weighted images[J].Magn Reson Med Sci, 2007, 6(3):147-155.DOI:10.2463/mrms.6.147.

[5]

Takenaka D, Ohno Y, Matsumoto K, et al.Detection of bone metastases in non-small cell lung cancer patients:Comparison of whole-body diffusion-weighted imaging(DWI), whole-body MR imaging without and with DWI, whole-body FDG-PET/CT, and bone scintigraphy[J].J Magn Reson Imaging, 2009, 30(2):298-308.DOI; 10.1002/jmri.21858. doi: 10.1002/jmri.21858

[6]

Adams HJA, Kwee TC, Vermoolen MA, et al.Whole-body MRI for the detection of bone marrow involvement in lymphoma:prospective study in 116 patients and comparison with FDG-PET[J].Eur radiol, 2013, 23(8):2271-2278.DOI:10.1007/s00330-013-2835-9.

[7]

Kwee TC, Fijnheer R, Ludwig I, et al.Whole-body magnetic resonace imaging, including diffusion-weighted imaging, for diagnosing bone marrow involvement in malignant lymphoma[J].Br J Haematol, 2010, 149(4):628-630.DOI:10.1111/j.1365-2141.2010.08093.x.

[8]

Brennan DD, Gleeson T, Coate LE, et al.A comparison of whole-body MRI and CT for the staging of lymphoma[J].AJR Am J Roentqenol, 2005, 185(3):711-716. doi: 10.2214/ajr.185.3.01850711

[9]

汤日杰, 桂思, 李建生, 等.¹⁸F-FDG PET/CT与大范围弥散磁共振成像评价非霍奇金淋巴瘤骨髓浸润的对比研究[J].中华血液学杂志, 2014, 35(3):231-235.DOI:10.3760/cma.j.issn.0253-2727.2014.03.011.
Tang RJ, Gui S, Li JS, et al.Comparison of ¹⁸F-FDG PET/CT and large-scale DWI for evaluation of non-Hodgkin lymphoma bone marrow infiltration[J].Chin J Hemorhed, 2014, 35(3):231-235. doi: 10.3760/cma.j.issn.0253-2727.2014.03.011

[10]

Kwee TC, Ludwig I, Uiterwaal CS, et al.ADC measurements in the evaluation of lymph nodes in patients with non-Hodgkin lymphom a:feasibility study[J].Magn Res Mater Phy, Biol Med, 2011, 24(1):1-8.DOI:10.1007/s10334-010-0226-7.

[11]

Kwee TC, de Klerk JM, Nievelstein RA.Imaging of bone marrow invo lvement in lymphoma:state of the art and future directions[J].Sci World J, 2011, 11:391-402.DOI:10.1100/tsw.2011.40.

[12]

Howe BM, Johnson GB, Wenger DE.Current concepts in MRI of focal and diffuse malignancy of bone marrow[J].Semin Musculoskelet Radiol.2013, 17(2):137-144.DOI:10.1055/s-0033-1343069.

[13]

Basu S, Torigian D, Alavi A.Evolving concept of imaging bone marrow metastasis in the twenty-first century:critical role of FDG-PET[J].Eur J Nucl Med Mol imaging, 2008, 35(3):465-471. doi: 10.1007/s00259-007-0593-0

[14]

Adams HJA, Kwee TC, Lokhorst HM, et al.Potential prognostic implications of whole-body bone marrow MRI in diffuse large B-cell lymphoma patients with a negative blind bone marrow biopsy[J].J Magn Reson Imaging, 2014, 39(6):1394-1400.DOI:10.1002/jmri.24318.

[15]

Tsunoda S, Takagi S, Tanaka O, et al.Clinical and prognostic significance of femoral marrow magnetic resonance imaging in patients with malignant lymphoma[J].Blood, 1997, 89(1):286-290. doi: 10.1182/blood.V89.1.286

[16]

Ribrag V, Vanel D, Leboulleux S, et al.Prospective study of bone marrow infiltration in aggressive lymphoma by three independe nt methods:whole-body MRI, PET/CT and bone marrow biopsy[J].Eur J Radiol, 2008, 66(2):325-331.DOI:10.1016/j.ejrad.2007.06.014.

[17]

闫瑾, 林祥通.PET预测及评价肿瘤疗效的新进展[J].国际放射医学核医学杂志, 2006, 30(4):214-217.
Yan J, Lin ST.The new advance of predication and advalution of tumor thera peutic effects by PET[J].Inter J Radiat Med Nucl Med, 2006, 30(4):214-217.

[18]

Khan AB, Barrington SF, Mikhaeel NG, et al.PET-CT staging of DLBCL accurately identifies and provides new insight into the clinical significance of bone marrow involvement[J].Blood, 2013, 122(1):61-67.DOI:10.1182/blood-2012-12-473389.

[19]

El-Galaly TC, d'Amore F, Mylam KJ et al.Routine bone marrow biopsy has little or no therapeutic consequence for positron emission tomography/computed tomography-staged treatment-naive patients with Hodgkin lymphoma[J].J Clin Oncol, 2012, 30(36):4508-4514.DOI:10.1200/JCO.2012.42.4036.

[20]

Littooij AS, Kwee TC, Barber I, et al.Whole-body MRI for initial staging of paediatric lymphoma:prospective comparison to an FDG-PET/CT-based reference standard[J].Eur Radiol, 2014, 24(5):1153-1165.DOI:10.1007/s00330-014-3114-0.

[21]

Ferrari1 C, Minoia C, Asabella AN, et al.Whole body magnetic resonance with diffusion weighted sequence with body signal suppression compared to ¹⁸F-FDG PET/CT in newly FDG PET/CT in newly diagnosed lymphoma diagnosed lymphoma[J].Hell J Nucl Med, 2014, Suppl1:40-49.

[22]

Abdulqadhr G, Molin D, Astrom G, et al.Whole-body diffusion-weighted imaging compared with FDG-PET/CT in staging of lymphoma patients[J].Acta Radiol, 2011, 52(2):173-180.DOI:10.1258/ar.2010.100246.

[23]

Wu X, Kellokumpu-Lehtinen PL, Pertovaara H, et al.Diffusion-weighted MRI in early chemotherapy response evaluation of patientswith diffuse large B-cell lymphoma-a pilot study:comparison with 2-deoxy-2-fluoro-D-glucose-positron emission tomography/computed tomography[J].NMR Biomed, 2011, 24(10):1181-1190.DOI; 10.1002/nbm.1689. doi: 10.1002/nbm.1689

[24]

Marina V, Milena R, Vesna P, et al.Complementary roles of bone scintigraphy and MR imaging in the detection and long-term follow-up of primary non-Hodgkin's bone lymphoma in a child-case report[J].Skeletal Radiol, 2015, 44(6):863-868.DOI:10.1007/s00256-014-2067-3.